| 8/11/2016 | BKCVIG | Fitch rates Amgen notes BBB
|
| 12/31/2013 | CV | Outlook 2014: U.S. primary market looks stronger after 'turning a corner' in Q4; terms may cheapen
|
| 8/26/2013 | CVIG | Moody's: Amgen view negative
|
| 2/4/2013 | CV | Market Commentary: Gilead Sciences steady ahead of earnings; Medtronic active; SandRidge lower on trust news
|
| 1/22/2013 | CV | Market Commentary: Amgen paper busy, higher as maturity nears; International Gaming firms after earnings
|
| 1/15/2013 | CV | Market Commentary: Amgen sees sellers ahead of maturity; Gilead Ds better; Lennar slips; Pacira to price
|
| 1/14/2013 | CV | Market Commentary: Dendreon adds outright; InterMune intends to price notes, shares; Lennar earnings on tap
|
| 1/8/2013 | CV | Market Commentary: Convertibles firm despite mixed underlying shares; short-dated, yield names strengthen
|
| 12/24/2012 | CV | Market Commentary: Convertibles quiet in shortened, pre-holiday session; Greatbatch trades higher on call
|
| 12/3/2012 | CV | Market Commentary: Teva trades after disappointing outlook; Volcano's planned $350 million convertible on tap
|
| 11/30/2012 | CV | Market Commentary: VeriSign drops outright in active trade but improves on hedge; larger, liquid names active
|
| 11/29/2012 | CV | Market Commentary: New Meritor trades flat despite higher shares; exiting Meritor active; Amgen up on hedge
|
| 10/23/2012 | CV | Market Commentary: RadioShack strengthens with buyback news; Gilead 'up small' ahead of earnings; AMD lower
|
| 10/2/2012 | CV | Market Commentary: WellPoint adds in the gray, models attractively; Molina, Amerigroup quiet; Illumina eyed
|
| 9/25/2012 | CV | Market Commentary: GT Advanced Technologies lifts despite lower shares; Navistar drops; Amgen, Gilead active
|
| 9/24/2012 | CV | Market Commentary: Planned GT Advanced looks cheap, lacks borrow; Suntech Power off from highs; Amgen active
|
| 9/10/2012 | BKCVIG | Fitch rates Amgen notes BBB
|
| 9/10/2012 | BKCVIG | S&P rates Amgen notes A+
|
| 9/10/2012 | BKCVIG | Moody's rates Amgen notes Baa1
|
| 9/7/2012 | CV | Market Commentary: Intel trades mixed to little changed after warning; NextEra adds 0.5 point dollar neutral
|
| 9/5/2012 | CV | Market Commentary: Toll Brothers trades unchanged on debut; Medicis in another 0.125 point; IG names active
|
| 8/31/2012 | CV | Market Commentary: Convertibles mostly flat for week; some see mixed performance for month, but indices gain
|
| 8/24/2012 | CV | Market Commentary: Convertibles mostly quiet; Gilead comes in slightly; Vertex static; Endo moves up a little
|
| 7/27/2012 | CV | Market Commentary: Amgen in line to slightly lower on earnings; Gilead, Coinstar in line as well; Amarin off
|
| 7/19/2012 | CV | Market Commentary: Amgen keeps tracking higher with shares; Xilinx gains on hedge; Kodak retakes 20; AMR up
|
| 7/5/2012 | CV | Market Commentary: Convertibles market quiet; Navistar steady before conference call; Patriot Coal around 30
|
| 6/27/2012 | CV | Market Commentary: High-grade names in focus; Lennar adds; Isis under pressure; Gevo to price $30 million
|
| 5/31/2012 | BKCVIG | S&P lifts health companies
|
| 5/10/2012 | CVIG | Fitch rates Amgen bonds BBB
|
| 5/10/2012 | CVIG | Moody's rates Amgen notes Baa1
|
| 5/10/2012 | CVIG | S&P rates Amgen notes A+
|
| 4/27/2012 | CV | Market Commentary: Amgen adds 0.25 point on hedge; Micron C notes weaker, but catches bid; Chesapeake pressured
|
| 4/24/2012 | CV | Market Commentary: Amgen trades little changed ahead of earnings; U.S. Steel slips; Tibco outperforms shares
|
| 4/11/2012 | CV | Market Commentary: New DFC Global rises to 104 on debut; new Prospect reoffered at 97.75; Micron launches
|
| 4/4/2012 | CV | Market Commentary: SanDisk 1.5% convertibles come in on hedge; NetApp trades in line; Western Refining adds
|
| 3/27/2012 | CV | Market Commentary: Lennar flat to slightly higher on hedge on earnings; Radian steady; Dendreon catches a bid
|
| 3/22/2012 | CV | Market Commentary: Shares of planned Cenveo plunge ahead of pricing; Amgen, Vornado, A123 Systems edge lower
|
| 3/13/2012 | CV | Market Commentary: New Salix pops, then retreats on debut; Medivation talk revised; Wintrust notes to price
|
| 2/13/2012 | CV | Market Commentary: Regeneron jumps after boosting sales outlook; Beazer launches exchange; iStar unchanged
|
| 2/10/2012 | CV | Market Commentary: Alcatel-Lucent up on strong earnings; Gilead, Amgen mixed on hedged basis; Siemens prices
|
| 2/8/2012 | CV | Market Commentary: Gilead edges up further on swap; RadioShack steady; Hutchinson jumps; solar names in focus
|
| 1/18/2012 | CV | Market Commentary: Amgen, Gilead improve on hedge; D.R. Horton, Synnex trade mostly in line; Cheniere slips
|
| 1/17/2012 | CV | Market Commentary: Life Technologies rises in active trading on call news; Amgen busy; Kingross loses ground
|
| 1/13/2012 | CV | Market Commentary: Patriot coal announces production cuts; coal sector suffers; Amgen 'big trading name'
|
| 1/9/2012 | CV | Market Commentary: Convertibles revert to 'quiet'; Alcoa firm to better ahead of earnings; Amgen steady
|
| 12/23/2011 | CV | Market Commentary: SunPower jumps on Total transactions; PHH slips further; market quiet ahead of holiday
|
| 12/21/2011 | CV | Market Commentary: Convertibles quiet; Salesforce better dollar neutral; Micron reports disappointing loss
|
| 12/20/2011 | CV | Market Commentary: Jefferies recoups, moves higher with positive earnings; Navistar looks better on earnings
|
| 12/19/2011 | CV | Market Commentary: Amgen edges higher; Gilead mixed to higher; Jefferies lower; MF Global adds a few points
|
| 11/30/2011 | CVIG | S&P rates Amgen notes A+
|
| 11/30/2011 | CVIG | Moody's: Amgen notes Baa1
|
| 11/29/2011 | CV | Market Commentary: AMR collapses after bankruptcy filing; Transocean Cs improve; Onyx seen lower on hedge
|
| 11/14/2011 | CVIG | Fitch rates Amgen bonds BBB
|
| 11/7/2011 | CVIG | Fitch downgrades Amgen
|
| 11/7/2011 | CVIG | Moody's cuts Amgen
|
| 11/7/2011 | CVIG | S&P rates Amgen notes A+
|
| 11/7/2011 | CV | Market Commentary: Jefferies adds after unwinding euro debt; Amgen unmoved on share buyback, debt deal
|
| 10/25/2011 | CV | Market Commentary: Convertibles weaken with equity slump; MF Global 'gets smoked' on earnings disappointment
|
| 10/25/2011 | CVIG | Moody's: Amgen view negative
|
| 10/24/2011 | CV | Market Commentary: Convertibles rise on light volume; Radian up; hedged players lose on RightNow's Oracle offer
|
| 10/21/2011 | CV | Market Commentary: SanDisk moves up on positive earnings; Old Nuance opens up; Investment-grade names active
|
| 10/20/2011 | CV | Market Commentary: Cubist improves dollar neutral; Ingersoll-Rand drops; low-premium names 'better for sale'
|
| 10/13/2011 | CV | Market Commentary: Clearwire extends gains on positive quarterly figures; United Therapeutics paper unchanged
|
| 10/4/2011 | CV | Market Commentary: DryShips' convertibles slip; Overall market hit by weakness; MGM falls; AMR rallies
|
| 9/30/2011 | CV | Market Commentary: Convertibles sell off; GMX, MGM trade lower; Kodak drops sharply on restructuring fears
|
| 9/29/2011 | CV | Market Commentary: Kodak extends losses even as stock rises; AMD slips, shares plunge; Cemex trades in line
|
| 9/16/2011 | CV | Market Commentary: Textron climbs on takeover talk; Alcoa benefits from tender hopes; Amgen, Genco active, flat
|
| 9/15/2011 | CV | Market Commentary: Suntech, JA Solar fall on downgrades; InterMune continues rising; EMC, Amgen climb higher
|
| 9/12/2011 | CV | Market Commentary: Global Industries surges on takeover offer; Hornbeck up 2-3 points; Clearwire weakens
|
| 8/31/2011 | CV | Market Commentary: Convertibles better; EMC, MF Global gain; stabilizing markets point to better September
|
| 8/24/2011 | CV | Market Commentary: Hedge players win on United Therapeutics; Amerigroup adds; investment-grade paper active
|
| 8/22/2011 | CV | Market Commentary: Kodak adds premium points; Clearwire steady at higher levels; Medtronic, Amgen, EMC firm
|
| 8/19/2011 | CV | Market Commentary: Salesforce up on earnings; hedged Micron beats tech woes; Amgen, EMC see flight to quality
|
| 8/12/2011 | CV | Market Commentary: Convertibles firm slightly; Tyson, United Rentals recouping; Microsoft little changed
|
| 8/11/2011 | CV | Market Commentary: High-grade paper mixed as strong equity rally cools convertibles; Bank of America in focus
|
| 7/18/2011 | CV | Market Commentary: Convertibles weak; Endeavour sells $120 million deal; WebMD collapses on lowered guidance
|
| 7/15/2011 | CV | Market Commentary: Electronic Arts opens higher on strong demand, rich pricing; Intel, AMD trade before earnings
|
| 7/12/2011 | CV | Market Commentary: Convertibles fall; Europe fears build with Ireland's downgrade; volumes low amid volatility
|
| 6/29/2011 | CV | Market Commentary: Liquid names in trade; U.S. Steel lags underlying shares; Cameron trades ahead of call
|
| 6/27/2011 | CVIG | S&P rates Amgen notes A+
|
| 6/27/2011 | CVIG | Moody's rates Amgen notes A3
|
| 6/27/2011 | CVIG | Fitch rates Amgen notes A-
|
| 5/19/2011 | CV | Market Commentary: Amgen active around 101; Molson Coors, Lam Research trade at steady pricing; WebMD adds
|
| 5/3/2011 | CV | Market Commentary: Mylan off outright, expands on hedge; Incyte premium comes in; Alaska Communications on tap
|
| 5/3/2011 | CVIG | Fitch cuts Amgen
|
| 4/28/2011 | CVIG | Moody's cuts Amgen to stable
|
| 4/20/2011 | CV | Market Commentary: EMC gains on earnings; Textron slips on miss; Amgen up ahead of report; Amylin continues rally
|
| 3/4/2011 | CVIGPF | Amgen files automatic shelf for stock, preferreds and debt securities
|
| 3/1/2011 | CVIG | Fitch affirms Amgen
|
| 2/16/2011 | CV | Market Commentary: Convertibles lackluster; Ciena trades mixed to higher; Radian gains; USEC mostly unchanged
|
| 2/4/2011 | CV | Outright convertible players add 1.9% for January, Citigroup says
|
| 2/2/2011 | CV | Market Commentary: EMC, Amgen paper steady to higher; Savient extends gains; D.R. Horton, Lennar in trade
|
| 1/25/2011 | CV | Citi says replace $15 billion of maturing converts with AngloGold, Boston Properties, among others
|
| 1/24/2011 | CV | Market Commentary: Salesforce.com under pressure; RadioShack lower; Molycorp plans mandatory; Nielsen on tap
|
| 1/21/2011 | CV | Market Commentary: Amgen, Micron convertibles higher dollar neutral; AMR slips; NovaMed gains on takeout
|
| 12/14/2010 | CV | Market Commentary: Amgen jumps in line on positive drug news; Transocean active; Home Inns prices; Swift on tap
|
| 12/7/2010 | CV | Market Commentary: Wintrust holds up amid lower shares; Evergreen active; UBS-Stillwater exchangeable on tap
|
| 11/24/2010 | CV | Market Commentary: Convertibles quiet ahead of Thanksgiving as positive data lifts shares; investors cautious
|
| 11/23/2010 | CV | Market Commentary: Convertibles take hit as shots fly between North, South Korea; market quiet before holiday
|
| 10/27/2010 | CV | Market Commentary: Digital River gains on debut; Equinix higher, in line; Energy XXI, Green Plains on tap
|
| 10/7/2010 | CV | Market Commentary: Amgen steady in active trade; Equinix continues to expand after warning; Alcoa quiet
|
| 9/23/2010 | CV | Market Commentary: Vertex Pharma adds on active debut; Avis, Hertz slip; Rite Aid down, but CBIZ adds to debut
|
| 9/13/2010 | CV | Market Commentary: Hertz comes 'in' a little on swap with better Dollar Thrifty bid; Level 3, Volcano on tap
|
| 9/13/2010 | CVIG | S&P rates Amgen notes A+
|
| 9/13/2010 | CVIG | Moody's rates Amgen notes A3
|
| 9/13/2010 | CVIG | Fitch rates Amgen notes A
|
| 9/10/2010 | CV | Market Commentary: UBS' new GT Solar mandatories slip below par on debut; Amgen trades in line with shares
|
| 7/30/2010 | CV | Market Commentary: A&P bonds recoup some losses; Gilead flat; Virgin Media slips; issuance tracks 2009 pace
|
| 7/29/2010 | CV | Market Commentary: Symantec, CommScope improve despite weak quarterly results; Life Technologies paper better
|
| 7/7/2010 | CV | Market Commentary: FTI Consulting richens despite revised outlook; Affymetrix steady; EMC gains after upgrade
|
| 7/2/2010 | CV | Market Commentary: Convertibles quiet; Lincare A paper improves dollar neutral; Informatica up; Helix firm
|
| 7/1/2010 | CV | Market Commentary: Amgen, Medtronic, Transocean trade in high volumes; ProLogis mixed; Ford price fluctuates
|
| 6/24/2010 | CV | Market Commentary: Shorter-dated high-grade names in trade; Transocean, Medtronic, Symantec in line; PPL up
|
| 6/21/2010 | CV | Market Commentary: Biovail gains on merger with Valeant; Amgen up on competitor's drug safety; PPL on tap
|
| 6/4/2010 | CV | Market Commentary: Convertibles weaken; Xilinx trades down on debut; Transocean, Amgen improve, then decline
|
| 6/4/2010 | CVIG | Moody's: Amgen outlook positive
|
| 6/2/2010 | CV | Market Commentary: Transocean extends fall, then bounces; Cameron steadies; Amgen sideways; REITs active
|
| 5/21/2010 | CV | Market Commentary: Convertibles unsteady; Amgen, Omnicare lower; Cemex firms; Symmetricom buying 3.25% notes
|
| 5/6/2010 | CV | Market Commentary: Equities plummet, then partially recover; some convertibles buyers step in after decline
|
| 4/23/2010 | CV | Market Commentary: Health care names recover; investment-grade names in focus; Incyte, Textron strengthen
|
| 4/21/2010 | CV | Market Commentary: MGIC soars on debut; Evergreen Solar active on new issue, tender; Gilead Sciences improves
|
| 4/12/2010 | CV | Market Commentary: Convertibles mixed; Transocean, Beckman active; ON Semi's 0s add on incentive; Quanta off
|
| 3/9/2010 | CVIG | S&P assigns Amgen notes A+
|
| 3/9/2010 | CVIG | Moody's gives Amgen notes A3
|
| 3/9/2010 | CVIG | Fitch affirms Amgen
|
| 2/25/2010 | CV | Market Commentary: Convertibles volume thin; CSG edges up on debut; Newmont Mining mixed, Capital Source quiet
|
| 2/19/2010 | CV | Market Commentary: Convertibles higher outright, but quiet; Amgen steady; Trico Marine down; LifePoint weaker
|
| 1/25/2010 | CV | Market Commentary: EMC extends losses ahead of earnings; Amgen, Boston Properties little changed; UAL drops
|
| 1/15/2010 | CV | Market Commentary: SanDisk, Bunge up on yield trades; Micron Technology slips with stock; Incyte down, active
|
| 1/7/2010 | CV | Market Commentary: Beazer Homes trades up with shares on debut; Alcoa weaker; Boston Properties active, steady
|
| 1/4/2010 | CV | Market Commentary: Big cap, investment-grade names dominate convertibles trading: Amgen adds, Transocean mixed
|
| 10/30/2009 | CV | Market Commentary: Amgen trades mixed after lawsuit news; Kodak quiet but still losing ground; AMR extends slide
|
| 10/5/2009 | CV | Market Commentary: UAL adds amid quiet trading; AMD gains; Medtronic up in solid volume; trading breadth narrow
|
| 9/28/2009 | CV | Market Commentary: Convertibles quiet; AMR steady; Newmont strengthens; Aspect Medical change of control eyed
|
| 9/22/2009 | CV | Market Commentary: AMR adds in gray, then upsizes; MannKind gains more: Goodrich, ATP, Incyte, Gaylord to price
|
| 9/21/2009 | CV | Market Commentary: AMR launches convertible; Amgen, MannKind, Nektar active in trade; Sonic, Kodak richen
|
| 9/18/2009 | CV | Market Commentary: Kodak, Sonic issues gain on debuts; older paper higher; Newmont rises; D.R. Horton strong
|
| 9/1/2009 | CV | Convertibles return nearly 4% for August, marking sixth straight positive month: Barclays Capital
|
| 8/27/2009 | CV | Market Commentary: NCI Building jumps on sweetened exchange; International Game gains; players eye primary
|
| 8/17/2009 | CV | Market Commentary: AMD, Intel, EMC lower as techs falter; Newmont slips with gold; Amgen declines with stock
|
| 7/27/2009 | CV | Market Commentary: Ford careens higher; Webster boosted by PIPE investment; Mylan mostly firm as shares drop
|
| 7/13/2009 | CV | Market Commentary: CIT loses more as liquidity worries go on; BofA, other financials improve; Vale, SBA trade
|
| 7/8/2009 | CV | Market Commentary: Amgen trades actively on positive trial news; Equinix dips but pares losses; Vale edges up
|
| 7/6/2009 | CV | Market Commentary: Investment-grade names attract buyers, improve; St. Mary Land active; Vale, Regis to price
|
| 6/24/2009 | CV | Market Commentary: Rambus convertibles add in quiet debut; LodgeNet quiet; PNC up as investors eye safety play
|
| 6/11/2009 | CV | Market Commentary: Amgen B paper active, lower; Alcoa nears double par; B of A extends gains; EMC, NetApp eyed
|
| 5/20/2009 | CV | Market Commentary: FPL trades steady to slightly lower on debut; Hertz gains in gray; Cephalon launches deal
|
| 4/29/2009 | CV | Market Commentary: U.S. Steel, SunPower gain on debuts; Textron moves up in gray; Qwest edges up, but UAL slips
|
| 2/26/2009 | CV | Market Commentary: Fifth Third, Huntington gain as financials rally; Sallie Mae, Amgen, Hologic decline on budget details
|
| 2/20/2009 | CVIG | Fitch affirms Amgen
|
| 1/26/2009 | CV | Market Commentary: Convertibles little changed: Wyeth steady on Pfizer deal; Amgen active ahead of earnings; AMD gains
|
| 1/21/2009 | CV | Market Commentary: Financial preferreds bounce a little from big drop; health care, biotech names in trade; Avnet edges higher
|
| 1/13/2009 | CVIG | Fitch gives Amgen notes A
|
| 1/13/2009 | CVIG | Moody's gives Amgen notes A3
|
| 1/13/2009 | CVIG | S&P rates Amgen notes A+
|
| 1/9/2009 | CV | Market Commentary: Convertibles little changed: NatCity, Amgen active but off week's highs; bank convertibles mixed
|
| 1/7/2009 | CV | Market Commentary: Amgen, Medtronic succumb to profit taking; Intel up; Liberty/Time Warner in line despite warnings
|
| 1/6/2009 | CV | Market Commentary: Convertibles add on stronger volume: Sprint/Nextel, NII Holdings, Alliant Techsystems strengthen
|
| 12/18/2008 | CV | Market Commentary: Convertibles stronger: Mylan adds 0.5 point; strong bid on IG names; Allergan 1.5% notes up to par
|
| 12/15/2008 | CV | Market Commentary: Convertibles mostly quiet; iStar Financial floaters little changed; Mylan weaker; Amgen strengthens
|
| 12/9/2008 | CV | Market Commentary: Ford, GM mixed to lower pending bill; Amgen eases; Fifth Third Bancorp, ON Semiconductor weaker
|
| 11/14/2008 | CV | Market Commentary: Convertibles mixed: EMC better; Amgen little changed to lower; Transocean wavers on weaker oil
|
| 11/5/2008 | CV | Market Commentary: Chesapeake gains on renewed takeover rumors; Bunge firms on merger headwinds; Amgen, Ford decline
|
| 11/3/2008 | CV | Market Commentary: Virgin Media jumps on bank amendment; Ford unmoved by weak sales; Amgen, Medtronic up with stocks
|
| 10/28/2008 | CV | Market Commentary: Equities boost convertibles; Vornado, Amgen climb; KeyCorp rises on TARP nod; Transocean still soft
|
| 10/15/2008 | CV | Market Commentary: Low bids drag convertibles lower; Sallie Mae, Virgin Media retrace gains; Amgen convertibles better
|
| 10/1/2008 | CV | Market Commentary: Convertible price dislocations plague market; Ford, Amgen off; ImClone little moved; Fannie Mae at parity
|
| 9/16/2008 | CV | Market Commentary: AIG future hangs in the balance; Wachovia retraces some losses; Amgen convertibles up on drug data
|
| 8/13/2008 | CVIG | S&P: Amgen outlook stable
|
| 7/28/2008 | CV | Market Commentary: Amgen gains on clinical results; financials weaker; new XM Satellite deal looks cheap; XL, PSS to price
|
| 7/25/2008 | CV | Market Commentary: Affymetrix down on quarterly loss; Amgen steady pre-earnings; Countrywide bondholders eye angles
|
| 7/2/2008 | CV | Market Commentary: Smithfield Foods jumps to 103 on debut; GM, Ford slide; Coal names drop with stocks; Amgen adds
|
| 5/20/2008 | CVIG | Fitch rates Amgen notes A
|
| 5/20/2008 | CVIG | S&P gives Amgen notes A+
|
| 5/20/2008 | CVIG | Moody's gives Amgen notes A3
|
| 5/19/2008 | CV | Market Commentary: Huntington remains firm, but Sallie Mae weakens; Medtronic softer ahead of earnings, but Hologic adds
|
| 5/13/2008 | CV | Moody's lowers Amgen
|
| 4/17/2008 | CVIG | Amgen files automatic shelf registration
|
| 4/10/2008 | CV | Market Commentary: Endo jumps on debut; takeout news lifts Millenium, other biotechs gain; NatCity in play
|
| 4/3/2008 | CV | Fitch rates Amgen A
|
| 3/13/2008 | CV | Market Commentary: Newmont Mining, Amgen gain; Coeur d'Alene adds on debut; Aspect Medical slumps
|
| 3/10/2008 | CV | Market Commentary: Convertible bonds weaken; Countrywide down 3 points; Level 3, Merrill active
|
| 2/22/2008 | CV | Market Commentary: Silver Standard muted on debut; EMC slips with stock; Amgen, Level 3 lower as markets end mixed
|
| 1/24/2008 | CV | Market Commentary: Bank of America removes the juice; National City opens flat; Kinross Gold sparkles
|
| 12/21/2007 | CVIG | Moody's rates Amgen loan A2
|
| 12/7/2007 | CV | Market Commentary: Prudential opens lower; Transocean stays active; Macrovision sinks on Gemstar-TV Guide deal
|
| 10/23/2007 | CV | Market Commentary: Level 3 hammered on earnings; Countrywide down on borrower bailout; Medtronic coming back?
|
| 10/5/2007 | CV | Market Commentary: Molina opens strong; Eastman Kodak, Symantec, Amgen, Level 3, Best Buy all up; EMC mixed
|
| 10/2/2007 | CV | Market Commentary: Ford convertibles rise as sales fall; GM up; EMC continues strong show; Amgen slips; CapLease launches new issue
|
| 9/12/2007 | CV | Market Commentary: Countrywide holds steady; XM up on merger speculation; Calpine rocked some more; usual suspects rounded up
|
| 9/7/2007 | CVIG | S&P affirms Amgen
|
| 8/24/2007 | CV | Market Commentary: Anthracite opens quietly, doesn't provide good test; Ford, Intel, Yahoo!, Peabody up; Amgen nudges down
|
| 8/22/2007 | CV | Market Commentary: Countrywide continues recovery; Amgen, BioMarin nudge up; Ford edges down; market mayhem 'dying down'
|
| 8/15/2007 | CV | Market Commentary: Countrywide, KKR Financial fall; VeriSign starts strong; Amgen slips; wider markets fall on news
|
| 7/31/2007 | CV | Market Commentary: RAIT Financial Trust, KKR Financial tumble; AmeriCredit stumbles; mortgage-linked convertibles dive
|
| 7/27/2007 | CV | Market Commentary: Medtronic, Amgen, EMC all active as investors run for cover; trading volume stays high
|
| 6/26/2007 | CV | Market Commentary: Gannett jumbo deal, GSI issue on tap; Huntsman surges on merger; Amgen slides; Medtronic rises
|
| 6/8/2007 | CV | Market Commentary: Bausch & Lomb unmoved by fading hopes of rival offer; Amgen, Intel, Ford recover; market still cautious
|
| 6/5/2007 | CV | Market Commentary: Amylin gains on debut; Integra higher, Ciena, Dendreon quiet in gray; Cogent, Panda launch unusual deals
|
| 5/23/2007 | CV | S&P: Amgen on watch
|
| 5/23/2007 | CV | Moody's cuts Amgen view to negative
|
| 5/15/2007 | CV | Market Commentary: Amgen holds firm; Ford gains on deal; Gold Reserve up on debut; NPS, Shuffle Master see takeout hopes
|
| 5/11/2007 | CV | Market Commentary: CACI climbs in debut; L-1 rises despite borrow concerns; Amgen slips further; Conseco gains on sentiment
|
| 5/10/2007 | CV | Market Commentary: Amgen falls under drug panel scrutiny; Alesco, Chesapeake gain early, end flat; CACI, L-1 quiet in gray
|
| 4/2/2007 | CV | Market Commentary: Cephalon improves on FDA letter; Amgen remains soft on safety risks; issue pipeline seen healthy
|
| 3/15/2007 | CV | Market Commentary: Stanley Works sprints off the blocks; Amgen retreats on Medicare review; Alpharma bright in gray market
|
| 3/9/2007 | CV | Market Commentary: PrivateBancorp gains on strong demand; West Pharmaceutical quiet on debut; Amgen slips on new labels
|
| 3/5/2007 | CV | Market Commentary: CompuCredit falls on sector troubles; Amgen gains on upgrade; EMC drops with stock; Barnes plans deal
|
| 3/2/2007 | CV | Amgen holders put $8.9 million LYONs, $2.24 billion zero-coupon convertibles
|
| 3/1/2007 | CV | Market Commentary: Amgen slips on inquiry, drug concerns; Gilead firms on trial results; Hospitality Properties absent in gray
|
| 1/29/2007 | CV | Market Commentary: Bristol-Myers gains amid takeover talk; Sunpower distribution could be tight; Amgen continues decline
|
| 1/26/2007 | CV | Market Commentary: Covanta takes off on debut; Halliburton drops on results, confusion; Amgen lower on earnings, drug data
|
| 1/22/2007 | CV | Market Commentary: Amgen gains on dispute news; Ford rises before results; XM ignores stock slide; Lexington launches deal
|
| 1/4/2007 | CV | Market Commentary: Intel climbs on raised estimates; Amgen rallies on upgrade; 2007 could return 11%-11.5%, Lehman says
|
| 12/1/2006 | CV | Market Commentary: JDS Uniphase firm on sector concerns; Goodrich quiet in debut; Amgen, Gilead hit on broad pullback
|
| 9/27/2006 | CV | Market Commentary: BearingPoint, Amkor slip on default woes; Red Hat falls outright with earnings; Brandywine plans deal
|
| 7/21/2006 | CV | Market Commentary: Amgen climbs with earnings; Halliburton, Schlumberger slip outright; PMC-Sierra tumbles on loss
|
| 6/26/2006 | CV | Market Commentary: Intel, Amgen under pressure; Inco rises; Chesapeake launches mandatories offering
|
| 6/20/2006 | CV | Market Commentary: Medtronic, Amgen fall prey to selling pressure; JetBlue adds; Actuant plunges
|
| 6/9/2006 | CV | Market Commentary: Advanced Medical brushes off Fitch downgrade; Gilead, Amgen, Trinity gain; L-3 unchanged
|
| 5/22/2006 | CV | Market Commentary: Transocean, Oil States slide on oil concerns; Amgen gains on upgrade; Cameron premium meets resistance
|
| 5/12/2006 | BTCV | New Issue: Merrill Lynch prices $15 million 3% capped appreciation notes linked to biotech stock basket
|
| 5/5/2006 | CV | Market Commentary: Safenet gains on earnings, stock buyback; Scottish Re widens after poor quarter; Finisar flat after rally
|
| 4/5/2006 | CV | Market Commentary: Conexant gains on report; ON Semiconductor up despite downgrade; Ciena struggles off the blocks
|
| 3/21/2006 | CV | Market Commentary: BioMarin comes in ahead of new issue; Casual Male seen as cheap; Vista delay could mean tech troubles
|
| 3/20/2006 | CV | Market Commentary: Kerzner buyout hurts hedge investors; BioMarin plans new deal; Time Warner Telecom offer seen as cheap
|
| 3/14/2006 | CV | Market Commentary: Fair Isaac plunges on fears of new rival product; Human Genome slides on mixed trial results
|
| 3/9/2006 | CV | Market Commentary: General Motors get boost from rumors of union deal; Transocean, Amgen stronger; MOL to launch deal
|
| 3/8/2006 | BTCV | Amgen files debt, stock shelf
|
| 3/3/2006 | CV | Market Commentary: Intel holds up on hedged basis despite stock slide; Citigroup says convertible arbitrage paid off in February
|
| 2/22/2006 | CV | Market Commentary: MeriStar dives on buyout news; QLT gains despite wider losses; Amgen strong
|
| 2/21/2006 | BTCV | New Issue: Goldman Sachs prices $14.3 million 0.75% notes mandatorily exchangeable for Amgen
|
| 2/17/2006 | CV | Market Commentary: Citadel gains on rumors of put-seeking hedge funds; Amgen's new issues continue week's climb
|
| 2/16/2006 | CV | Market Commentary: Amgen convertibles active in trade; Halliburton gains; XM Satellite lower
|
| 2/15/2006 | CV | Market Commentary: New Amgen convertibles lift in active trade; Cephalon rises on guidance, Delta Air Lines weakens
|
| 2/14/2006 | CV | Market Commentary: Amgen prices upsized $5 billion issue; Transocean takes a dive on flat outlook; Akela Capital calls it quits
|
| 2/14/2006 | BTCV | New Issue: Amgen's upsized $5 bln convertibles: 0.125%, up 11% for 5-year, 0.375%, up 10.5% for 7-year
|
| 2/13/2006 | BTCV | Moody's rates Amgen convertibles A2
|
| 2/13/2006 | CV | Market Commentary: Oil and gas plays Chesapeake, Nabors fall on lower oil prices; all eyes on Amgen, GM in week ahead
|
| 2/13/2006 | BTCV | Amgen $4 bln convertibles: 5-year talked at 0.125%-0.625%, 7-year at 0.375%-0.875%, both up 10-13%
|
| 2/13/2006 | BTCV | S&P rates Amgen convertibles A+
|
| 1/12/2006 | CV | Market Commentary: Convertibles market turns mostly lower; biotechs, autos, oil services down, but Six Flags gains
|
| 1/3/2006 | BTCV | New Issue: Lehman prices $10.72 million notes linked to Amgen at 0.25%, up 10.75%
|
| 12/19/2005 | BTCV | Moody's affirms Amgen
|
| 11/21/2005 | CV | Market Commentary: GM mixed in light trade, Ford flat, Incyte gains on Pfizer pact, but SFBC falls
|
| 11/7/2005 | CV | Market Commentary: Northwest, AMR higher as oil declines; Genzyme eases but Cephalon edges higher
|
| 11/3/2005 | CV | Market Commentary: Chesapeake, Qwest trade higher; Abgenix, Amgen rise, but ImClone lower; SFBC plunges
|
| 10/20/2005 | CV | Market Commentary: Convertibles market reverses course after strong start; Cypress pulled down; Amgen, biotechs weaker
|
| 10/19/2005 | CV | Market Commentary: Ford, Amgen eyed before earnings; Continental lower, but AMR higher; Mercury Interactive gains
|
| 9/20/2005 | CV | Market Commentary: US Airways, Toreador launch new deals, bringing calendar to five; Sepracor, Cephalon up
|
| 9/15/2005 | CV | Market Commentary: Airlines under pressure; GM, Ford mostly lower; Cephalon higher, Amgen firm
|
| 9/12/2005 | CV | Market Commentary: Northwest drops as other airline convertibles trade mixed; software names see better bids
|
| 9/8/2005 | CV | Market Commentary: Convertibles trade mixed, with Amgen, Nabors edging up, Cypress Semiconductor down
|
| 8/1/2005 | CV | Market Commentary: CommScope jumps, but Isolagen tumbles amid slightly weaker convertibles market
|
| 7/29/2005 | BTCV | Moody's cuts Amgen to stable, rates convertible A2
|
| 7/21/2005 | CV | Market Commentary: Cheniere Energy to price $300 million deal; selling hits convertibles as Treasuries slump
|
| 7/20/2005 | CV | Market Commentary: Amgen rises in mixed convertibles trading as earnings reports roil GM, Kodak, boost Wyeth
|
| 7/8/2005 | CV | Market Commentary: Biotechs, chips lead convertibles mostly higher; Charming Shoppes, Henry Schein trade higher
|
| 7/7/2005 | CV | Market Commentary: Biotechs up as convertibles find footing after early dip; airlines down; some oil and gas names extend gains
|
| 7/7/2005 | CV | Market Commentary: Biotechs up as convertibles find footing after early dip; airlines down; some oil and gas names extend gains
|
| 6/29/2005 | CV | Market Commentary: CV Therapeutics' new deal gains, supporting biotechs; Mirant trades in heavy volume; General Mills eases
|
| 5/5/2005 | CV | Amgen receives tenders of 95% of 0% convertibles in exchange
|
| 5/4/2005 | CV | Amgen extends exchange for 0% convertibles
|
| 4/6/2005 | CV | Amgen starts exchange for 0% convertibles
|
| 3/2/2005 | CV | Amgen says $1.59 billion LYONs put back, leaving $2.36 billion outstanding
|
| 2/22/2005 | CV | Amgen offers cash payment to holders who do not exercise put
|
| 11/15/2004 | CV | Moody's rates Amgen notes A2
|
| 9/30/2004 | CV | Market Commentary: Ford, GM convertibles see little traffic ahead of Sept sales; Schering-Plough shoots up
|
| 7/22/2004 | CV | New Issue: Goldman prices $16.6 million notes exchangeable for Amgen to yield 1.5%, up 24.875%
|
| 7/21/2004 | CV | New Issue: Goldman prices $13 million notes exchangeable for Amgen to yield 1.5%, up 24.75%
|
| 7/15/2004 | CV | Market Commentary: Caesars eases back to levels before Harrah's deal; EDS off 1.75-2.25 points on cut to junk
|
| 6/17/2004 | CV | Market Commentary: Chiron goes to 101, Advanced Medical to 103.5; Kellwood to 101.5; Delta reverses, heads up
|
| 3/29/2004 | CV | S&P: Amgen unaffected
|
| 3/17/2004 | CV | Market Commentary: Cytyc goes to 104.375; XL prices at tight end of revised talk; Saks, Greater Bay, CommScope appear
|
| 12/17/2003 | CV | S&P: Amgen unaffected by share buyback
|
| 11/14/2003 | CV | Market Commentary: Valeant 3s end at 103.75 bid, 4s end at 104.75 bid; Amgen converts resist slide with stock
|
| 10/20/2003 | CV | Market Commentary: Hedgies buying Calpine notes; Amgen loses 1-2 points ahead of earnings; Nextel up on buybacks
|
| 9/29/2003 | CV | Market Commentary: Gap, Charming Shoppes show mixed views on retail results; Pharma Resources gains 2.25
|
| 7/11/2003 | CV | Lehman finds options market signaling several converts have high dividend risk
|
| 6/20/2003 | CV | Moody's confirms GM, outlook still negative
|
| 2/24/2003 | CV | Market Commentary: Very slow trading day, with players hanging in shadows
|
| 1/2/2003 | CV | Market Commentary: Market unexpectedly lively as new year opens strongly
|
| 11/25/2002 | CV | New Issue: Salomon sells $35 million 10% Targets linked to Amgen
|
| 11/14/2002 | CV | New Issue: Merrill Lynch prices $45.52 million 7% callable Strides payable with Amgen
|
| 8/28/2002 | CV | Market Commentary: Nortel drags down networkers; Semtech pressures chip group
|
| 7/18/2002 | CV | S&P says Baxter charge raises questions
|
| 7/15/2002 | CV | Market Commentary: Converts close higher despite wild swing in stock markets
|
| 6/13/2002 | CV | S&P revises Omnicom outlook to negative
|
| 5/22/2002 | CV | Market Commentary: Adelphia firms on buzz of Rigas deal; Berkshire surprises with overnighter
|
| 5/9/2002 | CV | Market Commentary: Adelphia gains on asset sales news; Household lower on put speculation
|
| 3/21/2002 | CV | Moody's puts DDi convertible on review for downgrade
|
| 2/22/2002 | CV | Market Commentary: Convertibles mixed, flat on doubts, anxiety
|
| 2/22/2002 | CV | New Issue: Amgen $2.5 billion (proceeds) convertibles yield 1.125%, up 40%
|
| 2/22/2002 | CV | Moody's rates new Amgen convertible at A2
|
| 2/21/2002 | CV | Amgen $2.5 billion (proceeds) convertibles talked at 1.0-1.25% yield, up 40-45%
|
| 2/21/2002 | CV | Moody's confirms Key Energy, rates add-on notes at Ba3
|
| 2/21/2002 | CV | Market Commentary: Convertibles retreat amid selling as stocks backslide
|
| 11/29/2001 | CV | New Issue: UBS prices $27 million 10.5% GOALS linked to Amgen
|
| 11/21/2001 | CV | Market Commentary: Convertible market dips slightly, ready for break to digest new issues
|
